AAAAAA

   
Results: 1-11 |
Results: 11
Inhibition of fumarate reductase in Leishmania major and L-donovani by chalcones
Authors: Chen, M Zhai, L Christensen, SB Theander, TG Kharazmi, A
Citation: M. Chen et al., Inhibition of fumarate reductase in Leishmania major and L-donovani by chalcones, ANTIM AG CH, 45(7), 2001, pp. 2023-2029
Antimalarial natural products
Authors: Christensen, SB Kharazmi, A
Citation: Sb. Christensen et A. Kharazmi, Antimalarial natural products, BIOACTIVE COMPOUNDS FROM NATURAL SOURCES: ISOLATION CHARACTERISATION AND BIOLOGICAL PROPERTIES, 2001, pp. 379
Absolute configuration and antiprotozoal activity of minquartynoic acid
Authors: Rasmussen, HB Christensen, SB Kvist, LP Kharazmi, A Huansi, AG
Citation: Hb. Rasmussen et al., Absolute configuration and antiprotozoal activity of minquartynoic acid, J NAT PROD, 63(9), 2000, pp. 1295-1296
A simple and efficient separation of the curcumins, the antiprotozoal constituents of Curcuma longa
Authors: Rasmussen, HB Christensen, SB Kvist, LP Karazmi, A
Citation: Hb. Rasmussen et al., A simple and efficient separation of the curcumins, the antiprotozoal constituents of Curcuma longa, PLANTA MED, 66(4), 2000, pp. 396-398
Thapsigargin analogues for targeting programmed death of androgen-independent prostate cancer cells
Authors: Christensen, SB Andersen, A Kromann, H Treiman, M Tombal, B Denmeade, S Isaacs, JT
Citation: Sb. Christensen et al., Thapsigargin analogues for targeting programmed death of androgen-independent prostate cancer cells, BIO MED CH, 7(7), 1999, pp. 1273-1280
No increase in fracture incidence in patients treated for thyrotoxicosis in Malmo during 1970-74. A 20-year population-based follow-up
Authors: Hallengren, B Elmstahl, B Berglund, J Christensen, SB Elmstahl, S Johnell, O Thorngren, KG
Citation: B. Hallengren et al., No increase in fracture incidence in patients treated for thyrotoxicosis in Malmo during 1970-74. A 20-year population-based follow-up, J INTERN M, 246(2), 1999, pp. 139-144
The antileishmanial activity of novel oxygenated chalcones and their mechanism of action
Authors: Zhai, L Chen, M Blom, J Theander, TG Christensen, SB Kharazmi, A
Citation: L. Zhai et al., The antileishmanial activity of novel oxygenated chalcones and their mechanism of action, J ANTIMICRO, 43(6), 1999, pp. 793-803
Structure-activity studies: In vitro antileishmanial and antimalarial activities of anthraquinones from Morinda lucida
Authors: Sittie, AA Lemmich, E Olsen, CE Hviid, L Kharazmi, A Nkrumah, FK Christensen, SB
Citation: Aa. Sittie et al., Structure-activity studies: In vitro antileishmanial and antimalarial activities of anthraquinones from Morinda lucida, PLANTA MED, 65(3), 1999, pp. 259-261
Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B
Authors: Manning, CD Burman, M Christensen, SB Cieslinski, LB Essayan, DM Grous, M Torphy, TJ Barnette, MS
Citation: Cd. Manning et al., Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B, BR J PHARM, 128(7), 1999, pp. 1393-1398
Limonoids from Khaya senegalensis
Authors: Khalid, SA Friedrichsen, GM Kharazmi, A Theander, TG Olsen, CE Christensen, SB
Citation: Sa. Khalid et al., Limonoids from Khaya senegalensis, PHYTOCHEM, 49(6), 1998, pp. 1769-1772
Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4)inhibitor SB 207499 (Ariflo) in the guinea pig
Authors: Underwood, DC Bochnowicz, S Osborn, RR Kotzer, CJ Luttmann, MA Hay, DWP Gorycki, PD Christensen, SB Torphy, TJ
Citation: Dc. Underwood et al., Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4)inhibitor SB 207499 (Ariflo) in the guinea pig, J PHARM EXP, 287(3), 1998, pp. 988-995
Risultati: 1-11 |